Back
Day Range
$7.63
$7.78
52-Week Range
$6.19
$11.14
Volume
718,428
50D / 200D Avg
$8.93
/
$9.32
Prev Close
$7.58
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 16.9 | 0.4 |
| P/B | 1.2 | 2.9 |
| ROE % | 6.9 | 3.8 |
| Net Margin % | 5.3 | 3.9 |
| Rev Growth 5Y % | 10.0 | 10.0 |
| D/E | 1.7 | 0.2 |
Key Takeaways
Revenue grew 10.02% annually over 5 years — strong growth
Earnings grew 146.07% over the past year
Generating 751.14M in free cash flow
PEG of 0.09 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 9.82%
Cash machine — converts 194.53% of earnings into free cash flow
Growth
Revenue Growth (5Y)
10.02%
Revenue (1Y)0.20%
Earnings (1Y)146.07%
FCF Growth (3Y)N/A
Quality
Return on Equity
6.92%
ROIC6.36%
Net Margin5.34%
Op. Margin16.43%
Safety
Debt / Equity
1.66
Current Ratio2.51
Interest Coverage1.98
Valuation
P/E Ratio
16.85
P/B Ratio1.23
EV/EBITDA12.15
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.20% | Revenue Growth (3Y) | 4.71% |
| Earnings Growth (1Y) | 146.07% | Earnings Growth (3Y) | 202.07% |
| Revenue Growth (5Y) | 10.02% | Earnings Growth (5Y) | 19.60% |
| Profitability | |||
| Revenue (TTM) | 7.23B | Net Income (TTM) | 386.13M |
| ROE | 6.92% | ROA | 1.96% |
| Gross Margin | 35.70% | Operating Margin | 16.43% |
| Net Margin | 5.34% | Free Cash Flow (TTM) | 751.14M |
| ROIC | 6.36% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.66 | Current Ratio | 2.51 |
| Interest Coverage | 1.98 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 16.85 | P/B Ratio | 1.23 |
| P/S Ratio | 0.90 | PEG Ratio | 0.09 |
| EV/EBITDA | 12.15 | Dividend Yield | 0.02% |
| Market Cap | 6.51B | Enterprise Value | 14.42B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.23B | 7.21B | 6.59B | 6.06B | 4.93B |
| Net Income | 386.13M | 156.92M | 42.32M | 185.04M | 188.73M |
| EPS (Diluted) | 0.57 | 0.23 | 0.09 | 0.31 | 0.27 |
| Gross Profit | 2.58B | 2.79B | 2.48B | 2.21B | 1.96B |
| Operating Income | 1.19B | 1.19B | 782.32M | 782.44M | 595.06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 19.75B | 21.41B | 20.99B | 21.23B | 19.23B |
| Total Liabilities | 12.13B | 12.80B | 13.48B | 13.25B | 11.92B |
| Shareholders' Equity | 5.27B | 5.88B | 5.37B | 5.65B | 5.52B |
| Total Debt | 8.74B | 10.09B | 11.02B | 9.75B | 10.17B |
| Cash & Equivalents | 824.65M | 979.78M | 529.58M | 549.21M | 655.49M |
| Current Assets | 5.07B | 5.73B | 6.13B | 4.69B | 5.51B |
| Current Liabilities | 2.02B | 2.16B | 2.33B | 2.02B | 3.47B |